Drug intelligence / Profile preview

soy peptide

Development stage
Preclinical
Modality
Recombinant Proteins and Enzymes, Peptides
Administration
Oral, Topical
01

Overview

Soy peptide refers to a mixture of small peptides derived from the enzymatic hydrolysis of soy protein isolate. These bioactive peptides are rich in essential amino acids and are considered "complete proteins" for human nutrition. Soy peptides have been shown to possess various functional properties including immunomodulatory, antioxidant, hypocholesterolemic effects, and potential benefits for diabetes, obesity, serum lipids regulation, and undernutrition[1][2][3]. They can reprogram hepatic lipid metabolism and restore mitochondrial function in models of undernutrition[2][3]. Soy peptides are also used as conditioning agents in cosmetic products due to their beneficial effects on skin health[5]. In clinical studies and pilot trials they have demonstrated potential benefits such as improved quality of life among cancer patients experiencing weight loss[7], possible cognitive function support[8], and skin health improvements in postmenopausal women when consumed as part of the diet[6].

Other names
soy peptidessoybean peptideglycine soja (soybean) peptideglycine max (soybean) peptide
02

Targets

DPP-4 (Dipeptidyl Peptidase-IV)TAS1R1 (Taste receptor type 1 member 1)TLR4 (Toll-like receptor 4)

Beyond the preview

Go deeper on soy peptide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on soy peptide.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call